Posts Tagged 'lipitor diabetes in women'

Promising Statin Replacement Demonstrates Ability to Lower LDL Cholesterol

The 2014 Scientific Sessions at the American College of Cardiology highlighted a new class of cholesterol drugs aimed at lowering LDL. These drugs, called PSCK9 inhibitors, may be an effective substitute for widely used statins like Lipitor, Crestor and Zocor. An article by the Cleveland Clinic notes that this class of drugs may prove promising for situations in which statins are either ineffective or not tolerated well by the patient.

An alternative to statins is especially ...

continue reading...

How Do I File a Lipitor Lawsuit?

If you are one of the many women who developed diabetes while taking the statin Lipitor, you may be considering filing a lawsuit to try to recover compensation for the manufacturer’s negligence. Unfortunately, filing and pursuing a lawsuit is a complicated, expensive, and time-consuming proposition. Only by consulting with a qualified attorney can an injured woman ensure that all of the requirements for filing a lawsuit are met, because every case is different, and general information will ...

continue reading...

Does Lipitor Cause Diabetes?

Numerous lawsuits have been filed across the United States claiming that the highly popular medication Lipitor elevates blood sugar levels and causes diabetes in women. And women who developed diabetes while on Lipitor are now wondering whether the drug causes diabetes.

What is Lipitor?

Lipitor is a statin, which is a class of drugs that lowers a user’s cholesterol to help prevent stroke and heart disease. Although clinical studies have shown that Lipitor reduces the risk of stroke ...

continue reading...

First Lipitor Diabetes Lawsuit Set for July 2015

Lipitor diabetes lawsuits are startingOn July 1, 2015, the first Lipitor diabetes lawsuit trial is set to begin under guidelines of a multidistrict litigation. Lipitor is classified as a statin, a drug prescribed to reduce high cholesterol levels. More than 20 million people in the United States take statins to control their cholesterol.

In July 2013, an initial request to centralize various Lipitor lawsuits related to diabetes in women into a multidistrict litigation (MDL) was rejected ...

continue reading...

Ramon Lopez Appointed to Plaintiffs’ Executive Committee in Multidistrict Lipitor Litigation

Lopez McHugh principal partner Ramon LopezLopez McHugh LLP is pleased to announce that principal partner Ramon R. Lopez has been appointed to the Plaintiffs’ Executive Committee (PEC) in the multidistrict litigation (MDL) regarding Lipitor, titled In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation (MDL – 2502). 270 claims were filed against Pfizer, maker of Lipitor, and have been consolidated into this MDL, which was centralized in the United States District ...

continue reading...

New Study Links Lipitor with Diabetes

A new study contributes to a growing body of evidence linking the cholesterol-lowering drugs called statins, such as Lipitor, with a higher risk of diabetes.

The Legal Examiner reported that in a study of U.K. medical records by Harvard School of Public Health, results showed “Statin therapy was associated with 14 percent increased risk of type 2 diabetes” and “[i]nitiating atorvastatin and simvastatin was associated with increased risk of type 2 diabetes.” These results fuse with a ...

continue reading...
Page 2 of 3 123